Łukasz Berlicki

Łukasz Berlicki

Auto-generated profile, based on publicly available information

Łukasz Berlicki

Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMArtur Mucha
Artur Mucha
PKPaweł Kafarski
Paweł Kafarski
ŁBŁukasz Berlicki
Łukasz Berlicki

24 September 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
CCChiara Cabrele
Chiara Cabrele
TMTamás A. Martinek
Tamás A. Martinek
Oliver ReiserOliver Reiser
Oliver Reiser
ŁBŁukasz Berlicki
Łukasz Berlicki
The construction of bioactive peptides using β-amino acid-containing sequence patterns is a very promising strategy to obtain analogues that exhibit properties of high interest for medicinal chemistry applications. β-Amino acids have been shown to modulate the conformation, dynamics, and proteolytic susceptibility of native peptides. They can be either combined with α-amino acids by following specific patterns, which results in backbone architectures with well-defined orientations of the side chain functional groups, or assembled in de novo-designed bioactive β- or α,β-peptidic sequences. Such peptides display various biological functions, including antimicrobial activity, inhibition of protein–protein interactions, agonism/antagonism of GPCR ligands, and anti-angiogenic activity.

4 April 2011 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
PKPaulina Kosikowska-Adamus
Paulina Kosikowska-Adamus
ŁBŁukasz Berlicki
Łukasz Berlicki
Urease is the enzyme that catalyzes the hydrolysis of urea, which is involved in serious infections caused by Helicobacter pylori in the gastric tract, as well as Proteus and related species in the urinary tract. The necessity to treat such infections has stimulated intensive studies on various groups of urease inhibitors. Patent literature on urease inhibitors with possible applications in medicine is reviewed in this paper. Hydroxamic acids, phosphoramidates, urea derivatives, quinones and heterocyclic compounds constitute the major classes of structures with such activity. Until now, only one compound, acetohydroxamic acid, has been clinically used for the treatment of urinary tract infections by urease inhibition. Unfortunately, it exhibits severe side effects. Thus, it seems that the full potential of urease inhibition has not yet been fully explored. Several Japanese patents related to the use of herbal extracts as sources of polyphenolic urease inhibitors have been considered as complementary or alternative therapy; however, their accessibility is quite possibly due to reduced restrictions for the introduction of natural products to the market.

1 February 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
PWPaulina Wójcik
Paulina Wójcik
ŁBŁukasz Berlicki
Łukasz Berlicki

7 September 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KMKatarzyna Magiera-Mularz
Katarzyna Magiera-Mularz
LSLukasz Skalniak
Lukasz Skalniak
KZKrzysztof M. Zak
Krzysztof M. Zak
BMBogdan Musielak
Bogdan Musielak
EREwa Rudzinska‐Szostak
Ewa Rudzinska‐Szostak
THTad Holak
Tad Holak

22 August 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KMKatarzyna Macegoniuk
Katarzyna Macegoniuk
EGEwa Grela
Ewa Grela
JPJerzy Palus
Jerzy Palus
EREwa Rudzińska-Szostak
Ewa Rudzińska-Szostak
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka
ŁBŁukasz Berlicki
Łukasz Berlicki